Completed NA INTERVENTIONAL 2-arm NCT03539939

The Role of Smoking and Gingival Crevicular Fluid Markers on Coronally Advanced Flap Outcomes

Sponsor: Ege University

Updated 4 times since 2018 Last updated: May 25, 2018 Started: May 3, 2010 Primary completion: Jun 7, 2012 Completion: Jan 7, 2013

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT03539939, this NA trial focuses on Gingival Recession and Smoking and remains completed. Sponsored by Ege University, it has been updated 4 times since 2010, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA

First recorded

May 2010

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Ege University
University of Louisville

Data source: Ege University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.